{
    "organizations": [],
    "uuid": "144fb0bc5dcfabd70e5fd9e05c99d035d8902eab",
    "author": "",
    "url": "https://www.reuters.com/article/brief-insmed-reports-q1-loss-per-share-0/brief-insmed-reports-q1-loss-per-share-0-89-idUSASC09YYD",
    "ord_in_thread": 0,
    "title": "BRIEF-Insmed Reports Q1 Loss Per Share $0.89",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2, 2018 / 11:38 AM / Updated 4 minutes ago BRIEF-Insmed Reports Q1 Loss Per Share $0.89 Reuters Staff\nMay 2 (Reuters) - Insmed Inc:\n* INSMED REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE * Q1 LOSS PER SHARE $0.89\n* Q1 EARNINGS PER SHARE VIEW $-0.98 â€” THOMSON REUTERS I/B/E/S\n* PREPARING FOR POTENTIAL PRODUCT LAUNCH OF ALIS IN 4Q 2018\n* SUBMITTED NDA TO FDA FOR AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) IN NTM LUNG DISEASE CAUSED BY MAC; ANTICIPATES PRIORITY REVIEW\n* AS OF MARCH 31, 2018, INSMED HAD CASH AND CASH EQUIVALENTS OF $686.6 MILLION Source text for Eikon: Further company coverage:",
    "published": "2018-05-02T14:36:00.000+03:00",
    "crawled": "2018-05-02T15:30:49.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "report",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "insmed",
        "inc",
        "insmed",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "preparing",
        "potential",
        "product",
        "launch",
        "ali",
        "4q",
        "submitted",
        "nda",
        "fda",
        "amikacin",
        "liposome",
        "inhalation",
        "suspension",
        "ali",
        "ntm",
        "lung",
        "disease",
        "caused",
        "mac",
        "anticipates",
        "priority",
        "review",
        "march",
        "insmed",
        "cash",
        "cash",
        "equivalent",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}